Status:
COMPLETED
Metabolic and Vascular Effects of Statins in Untreated Dyslipidemic Diabetic Patients
Lead Sponsor:
University of Rome Tor Vergata
Conditions:
Type 2 Diabetes
Diabetic Dyslipidemia
Eligibility:
All Genders
50-75 years
Phase:
PHASE3
Brief Summary
Type 2 diabetes (T2D), because of impaired glucose regulation and consequent hyperglycemia, promotes the development of coronary heart disease. Secondary dyslipidemia is often associated with T2D and ...
Eligibility Criteria
Inclusion
- Type 2 diabetes in good glycemic control, treated with metformin alone.
- Untreated dyslipidemia.
- BMI \<30.
Exclusion
- History of cancer.
- History of cardiovascular diseases.
- Any other acute or cronic illness which requires administration of steroids or other drugs able to interfere with glucose metabolism.
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00854503
Start Date
September 1 2008
End Date
December 1 2010
Last Update
May 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rome Tor Vergata
Rome, Italy, 00133